Critical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation.
about
Evolving treatment strategies for colorectal cancer: a critical review of current therapeutic optionsWait-and-see treatment strategies for rectal cancer patients with clinical complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysisLocally advanced rectal cancer: does assessment of response after neoadjuvant chemoradiotherapy impact management?Multidisciplinary treatment of rectal cancer in 2014: where are we going?Paradigm shift in the management of rectal cancer.Organ preservation in rectal cancer patients following complete clinical response to neoadjuvant chemoradiotherapy: Long-term results in three patientsTransanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review.Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer.Update and debate issues in surgical treatment of middle and low rectal cancer.Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?Eastern Canadian Colorectal Cancer Consensus Conference 2013: emerging therapies in the treatment of pancreatic, rectal, and colorectal cancers.Pathological Assessment of Rectal Cancer after Neoadjuvant Chemoradiotherapy: Distribution of Residual Cancer Cells and Accuracy of Biopsy.Long-term survival without surgery following a complete response to pre-operative chemoradiotherapy for rectal cancer: A case seriesComplete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancerPredictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.Modern rectal cancer multidisciplinary treatment: the role of radiation and surgery.Clinical competence in the surgery of rectal cancer: the Italian Consensus Conference.MR imaging for rectal cancer: the role in staging the primary and response to neoadjuvant therapy.Surgeon perspectives on the use and effects of neoadjuvant chemoradiation in the treatment of rectal cancer: a comprehensive review of the literature.Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.Clinical and molecular diagnosis of pathologic complete response in rectal cancer.Management of colorectal T1 carcinoma treated by endoscopic resection from the Western perspective.A single institution's long-term follow-up of patients with pathological complete response in locally advanced rectal adenocarcinoma following neoadjuvant chemoradiotherapy.Surgery for colorectal polyps: histological features, current indications, critical points, future perspective and ongoing studies.Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers.Clinical Significance of the Endoscopic Finding in Predicting Complete Tumor Response to Preoperative Chemoradiation Therapy in Rectal Cancer.Commentary on neoadjuvant therapy followed by local excision and two-stage total mesorectal excision: a new strategy for sphincter preservation in locally advanced ultra-low rectal cancer.Complete clinical response to neoadjuvant chemoradiotherapy for rectal cancer: an Australasian perspective.Predictive clinical model of tumor response after chemoradiation in rectal cancer.Complete radiotherapy response in rectal cancer: A review of the evidence.Metabolic and molecular relative percentage coreduction in patients with locally advanced rectal cancer treated with neoadjuvant therapy.Morphologic predictors of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.Clinicopathological characteristics predict lymph node metastases in ypT0-2 rectal cancer after chemoradiotherapy.Clinical significance of VEGFR-2 and ¹⁸F-FDG PET/CT SUVmax pretreatment score in predicting the long-term outcome of patients with locally advanced rectal cancer treated with neoadjuvant therapy.High nodal positivity rates even in good clinical responders after chemoradiation of rectal cancer: is organ preservation feasible?Combined endorectal ultrasonography and strain elastography for the staging of early rectal cancer.Are We Predicting Disease Progress of the Rectal Cancer Patients Without Surgery After Neoadjuvant Chemoradiotherapy?¹⁸F-FDG PET/CT-based treatment response evaluation in locally advanced rectal cancer: a prospective validation of long-term outcomes.Local excision of low rectal cancer treated by chemoradiotherapy: is it safe for all patients with suspicion of complete tumor response?
P2860
Q26998617-35DA567D-36AB-4E76-8EEB-4E13B78B4F82Q28078809-5AA7057A-A33F-4843-8432-C528D2AD191BQ33886095-02800AFD-83D4-4D02-9A64-6A182490F666Q34093825-606777D1-1B5C-4F13-B75D-E31B6E714F48Q34981092-FDA2D030-B45E-411E-9CF7-67D75B7C603AQ35233370-F9A80FE0-E838-4921-BBD8-7879E3F44EF8Q35931639-F388A1C5-6D5A-43B5-AECB-4E91C59ADF11Q36358764-FA3C2192-A28B-46B1-96E3-4F2313BD096BQ36403031-FF3A47BA-D9CF-42B2-AA17-2AC351EDC2FFQ36476122-E8A6ADFA-31D3-415B-981F-887DB5A5EAE1Q36581449-6369EC05-785A-4FC6-907C-E7305C7F289FQ37323833-A7576806-14C6-4370-BE73-C6212B81E580Q37326759-803AE1A6-5D7E-400D-A2A9-149D9B2480C8Q37510632-08DD6F94-1B09-4D7B-A81F-8A647962889DQ37628506-AEF5733D-CDAB-4190-8966-07FA485D86D6Q38100653-5F4761E5-AF06-42F1-9DC9-47720F38EAF0Q38211316-1F6019FA-1FF5-4454-ABF6-D4AFB5E0A67BQ38222387-5AD9AC35-AB3A-4BD4-8B57-936809D53391Q38562040-3CBF55B8-9180-421B-8849-723B478E898DQ38563947-EA26667F-8415-4EFC-8506-13B04C784B85Q38594617-98032D6C-3477-41C1-8850-79D9A3B1F05AQ38683548-6EEBBFFA-A267-4F13-8205-17489899595DQ39019287-2A80CC1D-50FF-4013-B080-55FC1043B604Q39076006-99F51ABB-39EA-439C-A7ED-8F8F958F743AQ39277599-22B55869-2710-464E-A6C8-01D729A09B0FQ39553689-DE58C952-878B-4E80-A8AE-8601A15FEA17Q39583361-9EC7FFC3-C3E9-4B5A-B42D-4232F6368F07Q41319661-A7A08A2B-8DA9-441D-B37D-70E7AD7A8A4FQ41708765-E23423C2-2DA1-428A-974C-2E9FCFF7F425Q43084603-B627E2EE-F262-470A-B686-40D92D081F42Q43345082-D8AA225E-EA7B-4EB3-BE9E-8A21A264D945Q49467615-C2B1B38E-6F2B-48EF-BFB4-0058B7119B01Q50631955-CA958463-90D2-4742-A0D9-4A4F488913A2Q50878258-E5EA87B0-1A5D-48B7-B995-0CF74E4AF2DBQ50936327-52DD6857-811B-4814-BEC4-114774EE8FFEQ51045492-D96F52DA-3024-4490-81EA-5381E016C105Q53104993-87BEC5E7-CDAB-4571-8288-D97D0AAB7AC8Q53119631-0B60097E-A37B-45B5-A169-B7A6433BFB23Q53154643-FAE41E57-86F2-4DE1-8FDC-1D9CD9EE4F18
P2860
Critical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Critical appraisal of the 'wai ...... sponders after chemoradiation.
@en
type
label
Critical appraisal of the 'wai ...... sponders after chemoradiation.
@en
prefLabel
Critical appraisal of the 'wai ...... sponders after chemoradiation.
@en
P2860
P356
P1476
Critical appraisal of the 'wai ...... sponders after chemoradiation.
@en
P2093
R Glynne-Jones
P2860
P304
P356
10.1002/BJS.8732
P407
P577
2012-04-27T00:00:00Z